Draft guidelines regarding excessive pricing of patented medicines released
Federal price controls for patented medicines have been part of Canadian law for approximately 35 years. The Patented Medicine Prices Review Board’s (PMPRB) mandate is to prevent excessive pricing of patented...To view the full article, register now.
Already a subscriber? Click here to view full article